Dual Antiplatelet Therapy Clinical Trials

5 recruiting

Frequently Asked Questions

Common questions about Dual Antiplatelet Therapy clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 16 of 6 trials

Recruiting
Not Applicable

Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO IV-EPIC 38)

Arterial Occlusive DiseasesCardiovascular DiseasesCoronary Disease+22 more
Fondazione Ricerca e Innovazione Cardiovascolare ETS576 enrolled1 locationNCT06535568
Recruiting
Phase 4

Comparison Of Reduced DAPT Followed by P2Y12 Inhibitor Monotherapy With Prasugrel vs stAndard Regimen in STEMI Patients

Dual Antiplatelet TherapyST Elevated Myocardial Infarction
Research Maatschap Cardiologen Rotterdam Zuid1,656 enrolled26 locationsNCT05491200
Recruiting
Not Applicable

Ticagrelor-Based Dual Antiplatelet Therapy Duration in CABG

Coronary Artery DiseaseCoronary Artery Bypass GraftingSaphenous Vein+1 more
Kexiang Liu, MD300 enrolled1 locationNCT06981390
Recruiting

Efficacy and Safety of Short Duration of DAPT After GENOSS® DES Implantation in Patients with Coronary Artery Disease

Percutaneous Coronary InterventionDual Antiplatelet Therapy
Genoss Co., Ltd.1,000 enrolled1 locationNCT06075420
Recruiting

Efficacy and Safety of 1-year Duration of DAPT After GENOSS® DES Implantation in Patients with Coronary Artery Disease According to the Complex Higher-risk Procedure

Coronary Artery DiseasePercutaneous Coronary InterventionDual Antiplatelet Therapy
Genoss Co., Ltd.1,000 enrolled1 locationNCT06075433
Recruiting
Phase 4

Non-antithrombotic Therapy After Transcatheter Aortic Valve Implantation Trial

AspirinAortic StenosisTAVI(Transcatheter Aortic Valve Implantation)+2 more
OCEAN-SHD Study Group400 enrolled1 locationNCT06007222